The Long Run with Luke Timmerman - podcast cover

The Long Run with Luke Timmerman

Timmerman Reportsoundcloud.com
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Last refreshed:
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Download Metacast podcast app
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

Ep60: Tim Mayleben

Tim Mayleben, CEO of Esperion Therapeutics, on cholesterol-lowering meds.

Jan 14, 20201 hr 10 min

Ep59: David Baker

David Baker, University of Washington protein designer.

Dec 30, 20191 hr 2 min

Ep58: Jigar Raythatha

Jigar Raythatha of Constellation Pharma on epigenetic drug development.

Dec 03, 20191 hr 12 min

Ep57: John Alam

John Alam on Alzheimer's drug development.

Nov 26, 20191 hr 21 min

Ep56: Tim Springer

Tim Springer of Harvard Medical School on his career in science and biotech.

Nov 13, 20191 hr 5 min

Ep54: Aoife Brennan

CEO of Synlogic on developing synthetic biology-based drugs.

Oct 15, 20191 hr 6 min

Ep53: Phil Sharp

MIT biologist Phil Sharp on his early career.

Oct 01, 20191 hr 4 min

Ep52: Bruce Carter

Bruce Carter on developing a new tuberculosis drug.

Sep 18, 201946 min

Ep51: Ted Love

Ted Love of Global Blood Therapeutics on a new drug for sickle cell disease

Sep 03, 20191 hr 3 min

Ep50: Joel Marcus

Joel Marcus, chairman of Alexandria Real Estate Equities, on building in biotech clusters.

Aug 20, 20191 hr 5 min

Ep49: Janelle Anderson

Janelle Anderson on venture capital and off-the-shelf cell therapy at Century Therapeutics

Aug 08, 20191 hr 5 min

Ep48: Cindy Perettie

Cindy Perettie of Foundation Medicine on genomic analysis for cancer.

Jul 11, 20191 hr 2 min

Ep47: Laura Shawver

Laura Shawver on synthetic biology engineering of cancer drugs.

Jul 02, 20191 hr 11 min

Ep46: Liz O'Day

Liz O'Day on metabolite signatures for predicting cancer drug response.

Jun 12, 20191 hr 7 min

Ep45: Jay Bradner

Jay Bradner, president of Novartis Institutes for Biomedical Research, on his journey from open biology advocate to pharma leadership.

May 22, 20191 hr 11 min

Ep44: Sheila Gujrathi

Sheila Gujrathi, CEO of Gossamer Bio, immunologic drug developer

May 09, 20191 hr 12 min

Ep43: Jeff Jonas

Sage Therapeutics CEO on psychiatric drug development.

Apr 24, 20191 hr 12 min

Ep42: Carolyn Bertozzi

Carolyn Bertozzi on becoming a chemical biologist/glycobiologist.

Apr 09, 20191 hr 9 min

Ep41: Bob Langer

MIT's Bob Langer on his journey in science and entrepreneurship.

Mar 27, 20191 hr 7 min

Ep40: Serge Saxonov

Serge Saxonov on the single-cell analysis revolution.

Mar 13, 20191 hr 10 min

Ep39: Julia Owens

Julia Owens on pivoting, more than once, in a biotech startup.

Feb 26, 20191 hr 10 min

Ep36: George Scangos

George Scangos on building an infectious disease company

Jan 15, 20191 hr 7 min

Ep34: Ron Renaud

Ron Renaud on developing messenger RNA therapies.

Dec 26, 20181 hr 15 min

Ep33: Krishna Yeshwant

Krishna Yeshwant of GV on life at the intersection of tech and biotech.

Dec 11, 20181 hr 13 min
For the best experience, listen in Metacast app for iOS or Android